Etoposide sensitivity of radioresistant human glioma cell lines

Cancer Chemotherapy and Pharmacology

Volumn 41, Issue 2, 1997, Pages 93-97

  Beauchesne, P ^a,c   Bertrand, S ^b   N'Guyen, M J ^b   Christianson, T ^a   Dore, J F ^b   Mornex, F ^b   Bonner, J A ^a  

^a MAYO CLINIC   (United States)

^b CENTRE LÉON BÉRARD   (France)

^c UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Etoposide; Human malignant gliomas; Radioresistance; Topoisomerase II

Indexed keywords

DNA; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; TOPOISOMERASE 2 INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER CHEMOTHERAPY; CONCENTRATION RESPONSE; DRUG EFFICACY; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; KINETOPLAST; PRIORITY JOURNAL; PROTEIN CONTENT; RADIOSENSITIVITY;

EID: 0031930520     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050713     Document Type: Article

References (37)

1. Abe T, Hasegawa S, Taniguchi K, Yokomizo A, Kuwano T, Ono M, Mori T, Hori S, Kohno K, Kuwano M (1994) Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells. Int J Cancer 58: 860-864
2. Black P (1991) Brain tumours, part 1. N Engl J Med 21: 1471-1476
3. Black P (1991) Brain tumours, part 2. N Engl J Med 22: 1555-1564
4. Boiardi A, Silvani A, Milanesi I, Botturi M, Broggi G (1991) Primary glial tumour patients treated by combining cisplatin and etoposide. J Neuro oncol 11: 165-170
5. Boiardi A, Silvani A, Milanesi I, Botturi M, Broggi G (1992) Carboplatin combined with carmustine and etoposide in the treatment of glioblastoma. Ital J Neurol Sci 13: 717-722
6. Brown GA, McPherson J, Gu L, Hedley DW, Toso R, Deuchars KL, Freedman MH, Goldenberg GJ (1995) Relationship of DNA topoisomerase Ha and b expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines. Cancer Res 55: 78-82
7. Buronfosse A, Thomas C, Ginestet C, Dore JF (1994) Radio-sensitivity in vitro of clonogenic and non-clonogenic glioblastoma cells obtained from a human brain tumour. C R Acad Sci [III] 317: 1031-1041
8. Carney DN (1991) The pharmacology of intravenous and oral etoposide. Cancer 67: 299-302
9. Chamberlain MC (1993) Recurrent brainstem gliomas treated with oral VP 16. J Neuro Oncol 15: 133-139
10. Chresta CM, Masters JR, Hickman JA (1996) Hypersensitivity of human testicular tumours to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res 56: 1834-1841
11. Coons SW, Johnson PC, Shapiro JR (1995) Cytogenetic and flow cytometry DNA analysis of regional heterogeneity in a low grade human glioma. Cancer Res 55: 1569-1577
12. Dutrillaux B, Lejeune J (1971) Sur une nouvelle technique d'analyse du caryotype hymain. C R Acad Sci [III] 272: 2638-2640
13. Fine HA, Dear KBG, Loeffler JS, Black P, Canellos GP (1993) Meta-analysis of radiotherapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597
14. Fry MG, Chresta CM, Davis SM, Walker MC, Harris AL, Hartley JA, Masters JRW, Hickson ID (1991) Relationship between topoisomerase II level and chemosensitivity in human tumour cell lines. Cancer Res 51: 6592-6595
15. Giaccone G, Gazadar AF, Beck H, Zunino F, Capranico G (1992) Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression. Cancer Res 52: 1666-1674
16. Giocanti N, Hennequin C, Balosso J, Mahler M, Favaudon V (1993) DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide. Cancer Res 53: 2105-2111
17. Hainsworth JD, Greco FA (1995) Etoposide: twenty years later. Ann Oncol 6: 325-341
18. ISCN (1991) Guidelines for cancer cytogenetics. Supplement to an international system for human cytogenetic nomenclature. Karger, Basel
19. Jeremic B, Grujicic D, Jevremovic S, Stanisavljevic B, Milojevic L, Djuric L, Mijatovic L (1992) Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study. J Clin Oncol 7: 1074-1077
20. Jordan JP, Hand CD, Markowitz RS, Black P (1992) Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay. J Neuro Oncol 14: 19-35
21. Kasahara K, Fujiwara Y, Sugimoto Y, Nishio K, Tamura T, Matsuda T, Saijo N (1992) Determinants of response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer cell lines. J Natl Cancer Inst 84: 113-118
22. Kimmel DW, Shapiro JR, Shapiro WR (1987) In vitro drug sensitivity testing in human gliomas. J Neurosurg 66: 161-171
23. Kubo S, Matsutani M, Nakagawa K, Ogura T, Esumi H, Saijo N (1992) Participation of poly(ADP-ribose) polymerase in the drug sensitivity in human lung cancer cell lines. Cancer Res Clin Oncol 118: 244-248
24. Madajewicz S, Chowhan N, Iliya A, Roque C, Beaton R, Davis R, Fertman S, Meek A, Alvarez O, Pampati M, Tyson G (1991) Intracarotid chemotherapy with etoposide and cisplatin for malignant brain tumours. Cancer 67: 2844-2849
25. Masters JRW, Osborne EJ, Walker MC, Parris CN (1993) Hypersensitivity of human testis-tumor cell lines to chemotherapeutic drugs. Int J Cancer 53: 340-346
26. Minehan KJ, Bonner JA (1994) The interaction of etoposide with radiation: variation in cytotoxicity with the sequence of treatment. Life Sci 53: 237-242
27. Minford J, Pommier Y, Filipski J (1986) Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II. Biochemistry 25: 9-16
28. Mornex F, Nayel H, Taillandier L (1993) Radiation therapy for malignant astrocytomas in adults. Radiother Oncol 27: 181-191
29. Mornex F, Bertrand S, N'guyen MJ, Devriendt D, Beauchesne P, Buronfosse A, Lambin P, Kirchner AL, Bonmartin A, Dore JF (1994) Bases biologiques de la radiorésistance des astrocytomes de haut grade de malignité. Bull Cancer Radiother 81: 342-350
30. Mornex F, Beauchesne P, Bonner JA (1994) Association etoposide et radiothérapie: mécanismes d'interaction. Cah Oncol 3:227-234
31. Mousseau M, Cahuvin C, Nissou MF, Chaffanet M, Plantaz D, Pasquier B, Schaerer R, Benabid A (1993) A study of the expression of 4 chemoresistance-related genes in human primary and metastatic brain tumours. Eur J cancer 5: 753-759
32. Nakagawa H, Fujita T, Kubo S, Tsuruzono K, Yamada M, Tokiyoshi K, Miyawaki Y, Kanayama T, Kadota T, Hayakawa T (1994) Selective intra-arterial chemotherapy with a combination of etoposide and cisplatin for malignant gliomas: preliminary report. Surg Neurol 41: 19-27
33. Pommier Y, Kerrigan D, Schwartz R (1982) The formation and resealing of intracalator-induced DNA strand breaks in isolated L1210 cell nuclei. Biochem Biophys Res Commun 107: 576-583
34. Seabright M (1971) A rapid banding technique for human chromosomes. Lancet II: 971-972
35. Slevin ML (1991) The clinical pharmacology of etoposide. Cancer 67: 319-329
36. Tirelli U, D'incalci M, Canetta R, Tumulo S, Franchin G, Veronesi A, Galligioni E, Trovo MG, Rossi C, Grigoletto E (1984) Etoposide (vp 16-213) in malignant brain tumours: a phase II study. J Clin Oncol 2: 432-436
37. Walker MD, Strike TA, Sheline GE (1979) An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5: 1725-1731